Antimalarial drug touted by President Trump is linked to increased risk of death in coronavirus patients
By: By Ariana Eunjung Cha and Laurie McGinley
President Donald Trump said Monday that he is taking a malaria drug to protect against the new coronavirus, despite warnings from his own government that it should only be administered for COVID-19 in a hospital or research setting due to potentially fatal side effects.
President Trump spoke about taking antimalarial drug earlier this week. (Jim Lo Scalzo/ EPA-/Shutterstock)
A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Trump as a “game changer” in the fight against the virus had a significantly higher risk of death compared with those who did not.
The study, published Friday in the medical journal the Lancet, is the largest analysis to date of the risks and benefits of treating covid-19 patients with antimalarial drugs.
The sheer size of the study was convincing to some scientists.